TALIS BIOMEDICAL CORP - COM (TLIS)

CUSIP: 87424L108

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
17,503,358
Share change
-1,555,592
Total reported value
$70,170,000
Put/Call ratio
101%
Price per share
$4.01
Number of holders
45
Value change
-$11,964,983
Number of buys
23
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 87424L108?
CUSIP 87424L108 identifies TLIS - TALIS BIOMEDICAL CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TALIS BIOMEDICAL CORP - COM (TLIS) as of Q4 2021

As of 31 Dec 2021, TALIS BIOMEDICAL CORP - COM (TLIS) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,503,358 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, GREENLIGHT CAPITAL INC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, PRELUDE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and NORTHERN TRUST CORP. This page lists 45 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.